Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Progress in the development of vaccines for hepatitis C virus infection.

World journal of gastroenterology - 14 Nov 2015

Ghasemi Faezeh, Rostami Sina, Meshkat Zahra

Abstract excerpt

The hepatitis C virus (HCV), first described in 1989, is now a leading cause of liver cirrhosis and hepatocellular carcinoma. With more than 170 million people infected globally, this virus is a major public health issue. The current standard therapy is based on interferon in combination with ribavirin. This costly therapy often fails to completely clear the infection and is associated with adverse side effects....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Discovery
Share to Genotype
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Host-Pathogen Interactions

Share to Immunization

Share to Phenotype

Share to Viral Hepatitis Vaccines

Source

Open in PubMed Open full text

Identifiers

PMID: 26576087
DOI: 10.3748/wjg.v21.i42.11984
PMCID: PMC4641120

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Progress in the development of vaccines for hepatitis C virus infection.PMID 26576087Read ↗

Hepatitis C virus vaccines in the era of new direct-acting antivirals.Semantic proximity Read ↗

Prospects for prophylactic and therapeutic vaccines against hepatitis C virus.Semantic proximity Read ↗

Status of hepatitis C virus vaccination: Recent update.Semantic proximity Read ↗

Future landscape of hepatitis C research - Basic, translational and clinical perspectives.Semantic proximity Read ↗

[Molecular aspects of the antiviral response against hepatitis C virus implicated in vaccines development].Semantic proximity Read ↗

[Current status and strategy of the research on hepatitis C vaccine].Semantic proximity Read ↗

Hepatitis C virus management: potential impact of nanotechnology.Semantic proximity Read ↗

Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E VirusSemantic proximity Read ↗

Viral evasion and challenges of hepatitis C virus vaccine development.Semantic proximity Read ↗

Development of Virus-Like Particles (VLPs) for Hepatitis C Virus genotype 4: a novel approach for vaccine development in Egypt.Semantic proximity Read ↗

Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis CSemantic proximity Read ↗

Development of a dendritic cell vaccine encoding multiple cytotoxic T lymphocyte epitopes targeting hepatitis C virus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.